4.4. Analysis.
Comparison 4 Skin patch releasing norelgestromin 150 µg + EE 20 µg versus COC desogestrel 150 µg + EE 20 µg, Outcome 4 Discontinuation ‐ adverse events (6 or 13 cycles).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.